
Disc Medicine, Inc. — Investor Relations & Filings
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients with serious hematologic diseases. The company's research focuses on fundamental pathways of red blood cell biology to address a range of disorders. Its pipeline includes bitopertin, an investigational therapy for erythropoietic protoporphyria (EPP) for which a New Drug Application has been submitted for accelerated approval. Other clinical-stage programs are evaluating treatments for myelofibrosis-associated anemia and other conditions involving ineffective erythropoiesis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | |
| 8-K - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | |
| ARS - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | |
| DEF 14A - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | |
| 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-03-04 | English | |
| 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-27 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41373791 | 10-Q - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | ||
| 41373680 | 8-K - Disc Medicine, Inc. (0001816736) (Filer) | 2026-05-05 | English | ||
| 38193714 | ARS - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | ||
| 38179519 | DEF 14A - Disc Medicine, Inc. (0001816736) (Filer) | 2026-04-28 | English | ||
| 32898845 | 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-03-04 | English | ||
| 32898846 | 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-27 | English | ||
| 32898848 | 8-K - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-27 | English | ||
| 32898851 | 10-K - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-26 | English | ||
| 32898849 | 8-K - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-26 | English | ||
| 32898847 | 4 - DISC MEDICINE, INC. (0001816736) (Filer) | 2026-02-19 | English | ||
| 31848965 | 4 Filing | 2026-02-17 | English | ||
| 31848958 | 4 Filing | 2026-02-17 | English | ||
| 31848947 | 4 Filing | 2026-02-17 | English | ||
| 31848932 | 4 Filing | 2026-02-17 | English | ||
| 31848902 | 4 Filing | 2026-02-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Công ty Cổ phần Traphaco
Specializes in pharmaceutical R&D, manufacturing, and expor…
|
TRA | VN | Manufacturing |
|
Công ty Cổ phần Xuất nhập khẩu Y tế DOMESCO
Specializes in research, manufacturing, and distribution of…
|
DMC | VN | Manufacturing |
|
Công ty Cổ phần Y Dược phẩm Vimedimex
Pharmaceutical enterprise importing, exporting, and manufac…
|
VMD | VN | Manufacturing |
|
ConjuChem Biotechnologies Inc.
Develops long-acting therapeutic peptides using proprietary…
|
CJHMF | CA | Manufacturing |
|
Connect Biopharma Holdings Ltd
A clinical-stage biopharma developing therapies for T cell-…
|
CNTB | US | Manufacturing |
|
Consun Pharmaceutical Group Limited
Modern pharmaceutical enterprise specializing in Chinese Me…
|
1681 | KY | Manufacturing |
|
Context Therapeutics Inc.
Clinical-stage biopharma developing T cell engaging bispeci…
|
CNTX | US | Manufacturing |
|
Contineum Therapeutics, Inc.
Clinical-stage biopharma developing oral small molecule the…
|
CTNM | US | Manufacturing |
|
Coral Laboratories Ltd.
Develops, manufactures, and markets WHO-GMP pharmaceutical …
|
524506 | IN | Manufacturing |
|
Corbus Pharmaceuticals Holdings, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
CRBP | US | Manufacturing |
Disc Medicine, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31589/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31589 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31589 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31589 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31589}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Disc Medicine, Inc. (id: 31589)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.